Semaglutide found to have shocking benefit for liver disease patients in new study

Using semaglutide injections, scientists were capable to reverse life-threatening cases of liver illness successful a caller objective proceedings published successful The New England Journal of Medicine.

Semaglutide, which is traditionally a attraction for benignant 2 diabetes, was fixed to participants who had been diagnosed with a life-threatening signifier of liver illness called metabolic dysfunction associated steatohepatitis (MASH).

"This is simply a large measurement guardant successful the field," said Arun Sanyal, M.D., manager of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, successful a video from VCU. "It provides patients with further choices erstwhile we deliberation astir treating fatty liver disease."

JOE ROGAN GAVE UP DRINKING ALCOHOL FOR THIS ONE SIMPLE REASON

MASH is simply a terrible signifier of metabolic dysfunction-associated steatotic liver illness (MASLD), which was antecedently known arsenic non-alcoholic fatty liver disease, according to WebMD.

MASH is simply a terrible signifier of metabolic dysfunction-associated steatotic liver illness (MASLD), which was antecedently known arsenic non-alcoholic fatty liver disease. (iStock)

Both MASH and MASLD are marked by excessive abdominous successful the liver, which tin beryllium dangerous.

"Over time, the buildup of abdominous successful the liver tin pb to inflammation, liver fibrosis, cirrhosis and liver cancer," stated a property merchandise astir the study.

FIRST GLP-1 PILL FOR WEIGHT LOSS, DIABETES SHOWS SUCCESS IN LATE-PHASE TRIAL

Researchers chose to analyse semaglutide arsenic a imaginable attraction due to the fact that this people of cause has antecedently been shown to trim abdominous and liver scarring for radical with MASH.

Between 2021 and 2023, 800 randomly selected participants crossed 37 countries received once-weekly injections of either semaglutide oregon a placebo, the property merchandise stated. More than fractional had benignant 2 diabetes and astir 75% were obese.

Participants treated with semaglutide had improvements successful liver enzymes and different humor measures of liver fibrosis, on with 10.5% value loss.  (iStock)

After 72 weeks of treatment, 62.9% of participants had little inflammation and abdominous accumulation successful their livers.

In the placebo group, lone 34.3% of participants experienced a alteration successful symptoms.

"The liver really starts looking substantially amended nether the microscope successful these patients," noted Sanyal.

OZEMPIC, OTHER SEMAGLUTIDES LINKED TO HAIR LOSS: HERE'S WHAT TO KNOW

The researchers besides recovered that 36.8% of the semaglutide radical saw improvements successful their liver fibrosis, versus 22.4% successful the placebo group.

Participants treated with semaglutide besides saw improvements successful liver enzymes and humor measures of liver fibrosis, arsenic good arsenic 10.5% value loss. 

"I've been moving with GLP-1 treatments for 16 years and these results are hugely exciting."

Some adverse experiences were much communal successful the semaglutide group, including nausea, diarrhea, constipation and vomiting.

"Novo Nordisk continues to research semaglutide crossed metabolic and cardiovascular health, including MASH, a information with constricted attraction options for patients and healthcare professionals," said Anna Windle, PhD, elder vice president of objective development, aesculapian and regulatory affairs astatine Novo Nordisk, shaper of Ozempic and Wegovy, successful a property merchandise provided to Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"We are encouraged by these published findings successful the NEJM and what this could mean for patients. Based connected these data, we look guardant to moving with regulatory authorities to bring this imaginable caller attraction enactment to patients."

"While these results indispensable beryllium treated with caution, the investigation shows semaglutide tin beryllium an effectual instrumentality to dainty this precocious liver disease," said the person of the trial. (iStock)

"While these results indispensable beryllium treated with caution, the investigation shows semaglutide tin beryllium an effectual instrumentality to dainty this precocious liver disease," said pb researcher Professor Philip Newsome, manager of the Roger Williams Institute of Liver Studies astatine King's College London, successful the release.

CLICK HERE TO GET THE FOX NEWS APP

"I've been moving with GLP-1 treatments for 16 years and these results are hugely exciting," helium added.

Sanyal noted that semaglutide had antecedently been shown to beryllium beneficial for obesity, diabetes and bosom disease.

"Now we tin adhd liver illness to that list."

For much Health articles, visit www.foxnews.com/health

Looking ahead, the probe squad plans to stitchery information from astir 1,200 participants successful 37 countries for up to 5 years to find semaglutide's interaction connected semipermanent liver complications.